Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.17 is 39% below its 4-year average of -0.84, around the middle of its 4-year range (-2.01–-0.41).
13.97% above its 12-month average of -1.36.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.75.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.17
EARNINGS PER SHARE (EPS) AVG TTM
-1.36
EARNINGS PER SHARE (EPS) AVG 3Y
-0.92
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+13.97%
CURRENT VS 3Y AVG
-27.52%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
QT Imaging Holdings, Inc.
Market Cap
$36.28M
Earnings Per Share (EPS)
-1.17
TTM Avg
-1.36
3Y Avg
-0.92
5Y Avg
N/A
Market Cap
$36.51M
Earnings Per Share (EPS)
-2.13
TTM Avg
-3.42
3Y Avg
-5.72
5Y Avg
-5.72
Market Cap
$35.69M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$36.70M
Earnings Per Share (EPS)
-1.69
TTM Avg
-1.60
3Y Avg
-3.62
5Y Avg
-4.57
Market Cap
$35.57M
Earnings Per Share (EPS)
-1.96
TTM Avg
-0.82
3Y Avg
-0.31
5Y Avg
-0.18
Market Cap
$35.50M
Earnings Per Share (EPS)
-13.84
TTM Avg
-117.78
3Y Avg
-126.66
5Y Avg
-275.31
Market Cap
$37.94M
Earnings Per Share (EPS)
N/A
TTM Avg
-21.23
3Y Avg
-13.85
5Y Avg
-9.58
Market Cap
$37.89M
Earnings Per Share (EPS)
0.16
TTM Avg
0.06
3Y Avg
-0.19
5Y Avg
-0.28
Market Cap
$34.50M
Earnings Per Share (EPS)
-1.26
TTM Avg
-0.80
3Y Avg
-2.79
5Y Avg
-3.86
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | $36.28M | -1.17 | -1.36 | -0.92 | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.51M | -2.13 | -3.42 | -5.72 | -5.72 |
| EUDA Health Holdings Limited (EUDA)vs › | $35.69M | -2.56 | -5.45 | -15.27 | -9.79 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.70M | -1.69 | -1.60 | -3.62 | -4.57 |
| DocGo Inc. (DCGO)vs › | $35.57M | -1.96 | -0.82 | -0.31 | -0.18 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.50M | -13.84 | -117.78 | -126.66 | -275.31 |
| Incannex Healthcare Limited (IXHL)vs › | $37.94M | N/A | -21.23 | -13.85 | -9.58 |
| Nephros, Inc. (NEPH)vs › | $37.89M | 0.16 | 0.06 | -0.19 | -0.28 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | -1.26 | -0.80 | -2.79 | -3.86 |
| Elutia Inc (ELUT)vs › | $34.48M | 0.94 | -0.29 | -1.25 | -1.59 |
Trailing EPS (TTM)
$-1.17
Forward EPS (Est.)
$-1.11
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.01 |
| 2024-12-31 | -0.71 |
| 2023-12-31 | -0.54 |
| 2022-12-31 | -0.41 |
| 2021-12-31 | -0.55 |
